Header cover image

Argentinian (MERVAL) Pharma Industry Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies2
  • 7D-1.7%
  • 3M-18.4%
  • 1Y118.0%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 4.1%, driven by pullbacks from every company within the industry. In the past year, the industry has gained 119%.

Industry Valuation and Performance

Has the Argentinian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024AR$73.5bAR$43.6b-AR$10,287,966,966.006.9x-7.1x1.7x
Sun, 24 Mar 2024AR$72.1bAR$9.6b-AR$4,702,241,388.0045.7x-15.3x7.5x
Tue, 20 Feb 2024AR$87.7bAR$9.6b-AR$4,702,241,388.0066x-18.7x9.1x
Thu, 18 Jan 2024AR$69.6bAR$10.3b-AR$4,704,193,685.0037.8x-14.8x6.7x
Sat, 16 Dec 2023AR$63.5bAR$10.3b-AR$4,704,193,685.0033.6x-13.5x6.1x
Mon, 13 Nov 2023AR$54.6bAR$13.0b-AR$2,496,856,221.00n/a-21.9x4.2x
Wed, 11 Oct 2023AR$48.0bAR$13.0b-AR$2,496,856,221.00n/a-19.2x3.7x
Fri, 08 Sep 2023AR$46.8bAR$18.8b-AR$150,001,147.0017.2x-312.1x2.5x
Sun, 06 Aug 2023AR$43.3bAR$18.8b-AR$150,001,147.0013x-288.6x2.3x
Tue, 04 Jul 2023AR$42.5bAR$18.8b-AR$150,001,147.0013.5x-283.5x2.3x
Thu, 01 Jun 2023AR$41.3bAR$19.1bAR$209.1m132.9x197.7x2.2x
Sat, 29 Apr 2023AR$33.7bAR$19.1bAR$209.1m108.1x161.3x1.8x
Mon, 27 Mar 2023AR$32.0bAR$19.1bAR$209.1m102.6x153.1x1.7x
Wed, 22 Feb 2023AR$32.1bAR$13.7bAR$1.5b17.2x20.7x2.3x
Fri, 20 Jan 2023AR$32.4bAR$13.7bAR$1.5b17.7x20.9x2.4x
Sun, 18 Dec 2022AR$28.1bAR$13.8bAR$1.5b18.4x18.7x2x
Tue, 15 Nov 2022AR$27.6bAR$19.6bAR$1.4b19.9x20.3x1.4x
Thu, 13 Oct 2022AR$29.4bAR$19.7bAR$1.4b25x21.3x1.5x
Sat, 10 Sep 2022AR$25.4bAR$20.9bAR$1.4b24.5x18x1.2x
Mon, 08 Aug 2022AR$21.7bAR$17.8bAR$987.0m24.4x22x1.2x
Wed, 06 Jul 2022AR$19.7bAR$9.9bAR$101.3m148.6x194.5x2x
Fri, 03 Jun 2022AR$19.6bAR$9.9bAR$101.3m147.5x193.4x2x
Sun, 01 May 2022AR$19.7bAR$9.9bAR$101.3m148.1x194.5x2x
Tue, 29 Mar 2022AR$20.1bAR$9.9bAR$101.3m151.4x198.5x2x
Thu, 24 Feb 2022AR$21.0bAR$9.9bAR$101.3m156.2x207x2.1x
Sat, 22 Jan 2022AR$19.0bAR$9.9bAR$101.3m142.7x187.7x1.9x
Mon, 20 Dec 2021AR$19.6bAR$9.9bAR$101.3m147.5x193.6x2x
Wed, 17 Nov 2021AR$19.8bAR$7.0bAR$393.1m46.5x50.4x2.8x
Fri, 15 Oct 2021AR$19.2bAR$7.0bAR$393.1m44.9x48.7x2.7x
Sun, 12 Sep 2021AR$19.2bAR$7.0bAR$393.1m45x48.9x2.7x
Tue, 10 Aug 2021AR$19.6bAR$7.0bAR$393.1m45.9x49.8x2.8x
Mon, 03 May 2021AR$20.6bAR$6.6bAR$382.9m49.8x53.9x3.1x
Price to Earnings Ratio

53.9x


Total Market Cap: AR$20.6bTotal Earnings: AR$382.9mTotal Revenue: AR$6.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Argentinian Pharma Industry Price to Earnings3Y Average 40.8x202220232024
Current Industry PE
    There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 87% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Argentinian Pharma compare with similar industries?

AR Market5.03%
Healthcare-1.73%
Pharma-1.73%
Pharma-1.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ROSE

AR$91.50

Instituto Rosenbusch

7D

-10.3%

1Y

524.6%

RICH

AR$862.50

Laboratorios RichmondC.I.F

7D

-1.2%

1Y

110.4%